N.J. Admin. Code § 10:167A-1.30
Current through Register Vol. 57, No. 1, January 6, 2025
Reimbursement for legend drugs shall be limited to manufacturers who have entered into a PAAD rebate agreement, including an agreement to pay rebates on claims for which PAAD is a secondary payer, with the Department of Human Services through the Division of Medical Assistance and Health Services pursuant to N.J.A.C. 10:51-1.22.
N.J. Admin. Code § 10:167A-1.30
See: 30 N.J.R. 2197(a), 30 N.J.R. 3309(a).
Recodified from N.J.A.C. 8:83C-1.27 by R.1999 d.148, effective 5/3/1999.
See: 30 N.J.R. 4109(a), 31 N.J.R. 1197(b).
Recodified from N.J.A.C. 8:83C-1.28 by R.2003 d. 248, effective 6/16/2003.
See: 34 N.J.R. 3456(a), 35 N.J.R. 2642(a).